Free Trial
NYSE:STE

STERIS (STE) Stock Price, News & Analysis

$221.72
+3.88 (+1.78%)
(As of 07/12/2024 ET)
Today's Range
$216.73
$223.01
50-Day Range
$209.52
$235.89
52-Week Range
$195.47
$254.00
Volume
371,999 shs
Average Volume
477,889 shs
Market Capitalization
$21.92 billion
P/E Ratio
58.04
Dividend Yield
0.94%
Price Target
$241.60

STERIS MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
9.0% Upside
$241.60 Price Target
Short Interest
Healthy
3.00% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.00
Upright™ Environmental Score
News Sentiment
1.08mentions of STERIS in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$1.80 M Sold Last Quarter
Proj. Earnings Growth
8.87%
From $9.24 to $10.06 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.33 out of 5 stars

Medical Sector

134th out of 917 stocks

Surgical Appliances & Supplies Industry

6th out of 18 stocks

STE stock logo

About STERIS Stock (NYSE:STE)

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

STE Stock Price History

STE Stock News Headlines

Analysts Set STERIS plc (NYSE:STE) Price Target at $241.60
Billionaire opens new pathway to wealth for investors
I’ve been a financial analyst for almost three decades, but I don’t think I’ve ever seen anything quite like this before.
Q4 2024 STERIS plc Earnings Call
Billionaire opens new pathway to wealth for investors
I’ve been a financial analyst for almost three decades, but I don’t think I’ve ever seen anything quite like this before.
Piper Sandler Reaffirms Their Hold Rating on Steris (STE)
STERIS Announces Dividend of $0.52 per share
See More Headlines
Receive STE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STERIS and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/08/2024
Ex-Dividend for 6/26 Dividend
6/12/2024
Dividend Payable
6/26/2024
Today
7/13/2024
Next Earnings (Estimated)
8/06/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
Health Care Equipment
CUSIP
85915210
Employees
18,179
Year Founded
1987

Price Target and Rating

Average Stock Price Target
$241.60
High Stock Price Target
$265.00
Low Stock Price Target
$215.00
Potential Upside/Downside
+9.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
6 Analysts

Profitability

Net Income
$378.24 million
Pretax Margin
13.68%

Debt

Sales & Book Value

Annual Sales
$5.14 billion
Cash Flow
$14.29 per share
Book Value
$63.91 per share

Miscellaneous

Free Float
97,726,000
Market Cap
$21.92 billion
Optionable
Optionable
Beta
0.83

Social Links

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

STE Stock Analysis - Frequently Asked Questions

How have STE shares performed this year?

STERIS's stock was trading at $219.85 at the start of the year. Since then, STE shares have increased by 0.9% and is now trading at $221.72.
View the best growth stocks for 2024 here
.

How were STERIS's earnings last quarter?

STERIS plc (NYSE:STE) announced its quarterly earnings results on Wednesday, May, 8th. The medical equipment provider reported $2.58 EPS for the quarter, beating the consensus estimate of $2.41 by $0.17. The company's revenue for the quarter was up 10.8% on a year-over-year basis.
Read the conference call transcript
.

What is Walter M. Rosebrough, Jr.'s approval rating as STERIS's CEO?

196 employees have rated STERIS Chief Executive Officer Walter M. Rosebrough, Jr. on Glassdoor.com. Walter M. Rosebrough, Jr. has an approval rating of 79% among the company's employees.

Who are STERIS's major shareholders?

Top institutional investors of STERIS include Blue Zone Wealth Advisors LLC (0.02%), SG Americas Securities LLC (0.02%), Gulf International Bank UK Ltd (0.02%) and First Hawaiian Bank (0.02%). Insiders that own company stock include Michael J Tokich, John Adam Zangerle, Mohsen Sohi, Cary L Majors, Renato Tamaro, Jacqueline B Kosecoff, Karen L Burton and Cynthia L Feldmann.
View institutional ownership trends
.

How do I buy shares of STERIS?

Shares of STE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of STERIS own?

Based on aggregate information from My MarketBeat watchlists, some other companies that STERIS investors own include Johnson & Johnson (JNJ), Home Depot (HD), AT&T (T), Visa (V), AbbVie (ABBV), Abbott Laboratories (ABT) and Pfizer (PFE).

This page (NYSE:STE) was last updated on 7/13/2024 by MarketBeat.com Staff

From Our Partners